906 related articles for article (PubMed ID: 8794770)
1. Purification of bovine thymus cytosolic C-terminal Src kinase (CSK) and demonstration of differential efficiencies of phosphorylation and inactivation of p56lyn and pp60c-src by CSK.
Cheng HC; Bjorge JD; Aebersold R; Fujita DJ; Wang JH
Biochemistry; 1996 Sep; 35(36):11874-87. PubMed ID: 8794770
[TBL] [Abstract][Full Text] [Related]
2. Sequence specificity of C-terminal Src kinase (CSK)--a comparison with Src-related kinases c-Fgr and Lyn.
Ruzzene M; Songyang Z; Marin O; Donella-Deana A; Brunati AM; Guerra B; Agostinis P; Cantley LC; Pinna LA
Eur J Biochem; 1997 Jun; 246(2):433-9. PubMed ID: 9208935
[TBL] [Abstract][Full Text] [Related]
3. Peptide and protein phosphorylation by protein tyrosine kinase Csk: insights into specificity and mechanism.
Sondhi D; Xu W; Songyang Z; Eck MJ; Cole PA
Biochemistry; 1998 Jan; 37(1):165-72. PubMed ID: 9425036
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
5. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylation of Src mutants at Tyr 527 in fibroblasts does not correlate with in vitro phosphorylation by CSK.
MacAuley A; Okada M; Nada S; Nakagawa H; Cooper JA
Oncogene; 1993 Jan; 8(1):117-24. PubMed ID: 7678701
[TBL] [Abstract][Full Text] [Related]
7. The amino-terminal half of pp59c-fyn contains sequences necessary for formation of a 75 kDa form and also repressive elements absent in pp60c-src.
Espino PC; Chou WY; Smith AE; Cheng SH
Oncogene; 1992 Feb; 7(2):317-22. PubMed ID: 1372400
[TBL] [Abstract][Full Text] [Related]
8. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
[TBL] [Abstract][Full Text] [Related]
9. Structural elements and allosteric mechanisms governing regulation and catalysis of CSK-family kinases and their inhibition of Src-family kinases.
Ia KK; Mills RD; Hossain MI; Chan KC; Jarasrassamee B; Jorissen RN; Cheng HC
Growth Factors; 2010 Oct; 28(5):329-50. PubMed ID: 20476842
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of a pp60c-src-related tyrosine kinase that effectively phosphorylates a synthetic peptide derived from p34cdc2.
Litwin CM; Cheng HC; Wang JH
J Biol Chem; 1991 Feb; 266(4):2557-66. PubMed ID: 1703531
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements for the efficient regulation of the Src protein tyrosine kinase by Csk.
Koegl M; Courtneidge SA; Superti-Furga G
Oncogene; 1995 Dec; 11(11):2317-29. PubMed ID: 8570183
[TBL] [Abstract][Full Text] [Related]
12. A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases.
Cheng HC; Nishio H; Hatase O; Ralph S; Wang JH
J Biol Chem; 1992 May; 267(13):9248-56. PubMed ID: 1577758
[TBL] [Abstract][Full Text] [Related]
13. Characterization of two activated mutants of human pp60c-src that escape c-Src kinase regulation by distinct mechanisms.
Bjorge JD; Bellagamba C; Cheng HC; Tanaka A; Wang JH; Fujita DJ
J Biol Chem; 1995 Oct; 270(41):24222-8. PubMed ID: 7592628
[TBL] [Abstract][Full Text] [Related]
14. Rapid and efficient purification of Src homology 2 domain-containing proteins: Fyn, Csk and phosphatidylinositol 3-kinase p85.
Koegl M; Kypta RM; Bergman M; Alitalo K; Courtneidge SA
Biochem J; 1994 Sep; 302 ( Pt 3)(Pt 3):737-44. PubMed ID: 7524477
[TBL] [Abstract][Full Text] [Related]
15. Regulation of c-Src tyrosine kinase activity by the Src SH2 domain.
Liu X; Brodeur SR; Gish G; Songyang Z; Cantley LC; Laudano AP; Pawson T
Oncogene; 1993 May; 8(5):1119-26. PubMed ID: 7683128
[TBL] [Abstract][Full Text] [Related]
16. CSK: a protein-tyrosine kinase involved in regulation of src family kinases.
Okada M; Nada S; Yamanashi Y; Yamamoto T; Nakagawa H
J Biol Chem; 1991 Dec; 266(36):24249-52. PubMed ID: 1722201
[TBL] [Abstract][Full Text] [Related]
17. Activation of pp60c-src transforming potential by mutations altering the structure of an amino terminal domain containing residues 90-95.
Potts WM; Reynolds AB; Lansing TJ; Parsons JT
Oncogene Res; 1988; 3(4):343-55. PubMed ID: 2465527
[TBL] [Abstract][Full Text] [Related]
18. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
Chong YP; Mulhern TD; Cheng HC
Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
[TBL] [Abstract][Full Text] [Related]
19. A synthetic peptidic substrate of minimal size and semioptimal sequence for the protein tyrosine kinase pp60c-src.
Ramdas L; Obeyesekere NU; McMurray JS; Budde RJ
Arch Biochem Biophys; 1996 Feb; 326(1):73-8. PubMed ID: 8579374
[TBL] [Abstract][Full Text] [Related]
20. Selective binding of activated pp60c-src by an immobilized synthetic phosphopeptide modeled on the carboxyl terminus of pp60c-src.
Roussel RR; Brodeur SR; Shalloway D; Laudano AP
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10696-700. PubMed ID: 1720546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
